About UsServices
· Market Intelligence· Strategy & Growth· Trade Execution
Industries
· Healthcare· FMCG· Sustainability
Insights
· Articles· Blogs· Case Studies
CareersContact
Home
›
Services
›
Trade & Execution
Trade & Execution

Intelligence that
moves markets
and closes deals.

Winning in the market requires more than strategy. It demands real-time intelligence on trade dynamics, channel behaviour, regulatory landscapes, and the people who influence decisions at the point of purchase and prescription. We deliver the execution intelligence that turns commercial plans into commercial results.

Discuss an Execution Brief →
01
Trade Intelligence

Trade & Margin Intelligence

Understand how your product moves through the trade , and where margin leaks before it reaches the consumer.

?
Margins rarely erode in one place. They get diluted across pricing decisions, trade structures, and everyday commercial compromises. The question we answer: Where are you truly making money, where are you losing it, and how do you fix it without slowing down growth?
What we do
Break down how margins flow across distributors, retailers, and partners
Identify where pricing and discounting are working against you
Evaluate the real impact of trade schemes and incentives
Understand profitability across products, channels, and accounts
Highlight structural issues that quietly erode value
What you gain
Clarity on where profit is created and where it is lost
Visibility into hidden leakages across the system
Better decisions on pricing, trade spend, and negotiations
A healthier balance between growth and profitability
Right for you if
Revenue is growing but margins are under pressure
Trade investments feel high but outcomes are unclear
Pricing decisions are reactive rather than strategic
You suspect value is leaking but cannot pinpoint where
02
Regulatory Intelligence

Regulatory & Access Intelligence

Navigate regulatory complexity before it becomes a commercial barrier. Intelligence-led access strategy across markets.

?
Even the strongest strategy depends on access. Regulatory pathways, pricing structures, and market dynamics often decide what actually reaches the market. The question we answer: What stands in the way of access, and how do you navigate it in a way that supports both speed and sustainability?
What we do
Understand regulatory pathways and approval processes
Identify barriers that delay or limit access
Analyse pricing and reimbursement dynamics
Assess risks and compliance gaps
Compare how competitors are navigating similar challenges
What you gain
Clear visibility into access risks and opportunities
Better preparedness for regulatory and market challenges
More effective market entry and expansion strategies
Stronger alignment between commercial and regulatory decisions
Right for you if
You are entering complex or regulated markets
Approval timelines are uncertain or delayed
Access is limiting your growth potential
Pricing and reimbursement are difficult to navigate
03
KOL Intelligence

Physician & KOL Intelligence

Know who influences prescribing decisions , and how to engage them with credibility and commercial precision.

?
In many categories, decisions are shaped long before the consumer acts. They are influenced by people who are trusted, credible, and often invisible in traditional analysis. The question we answer: Who truly influences decisions in your ecosystem, and how do you engage them in a way that builds credibility and impact?
What we do
Identify the individuals and networks that shape decisions
Understand how influence flows across physicians and key opinion leaders
Analyse what drives trust, engagement, and advocacy
Evaluate how competitors are building influence
Identify gaps in your current engagement approach
What you gain
A clearer picture of who matters and why
More focused and effective engagement with key influencers
Stronger credibility within the ecosystem
Better alignment between your brand and expert voices
Right for you if
Expert influence plays a critical role in adoption
Your KOL strategy feels fragmented or unclear
You are entering or scaling in a specialised category
Competitors have stronger influence in key networks
04
Channel Intelligence

Retail & Channel Intelligence

Know how your product performs at the shelf, in the pharmacy, and across every channel before your competitors do.

?
Growth often looks strong on paper, but breaks down in the channel. Products are listed but not sold. Distribution is wide but not effective. Execution varies more than it should. The question we answer: Where is your channel truly working, where is it breaking, and what needs to change to make it deliver consistent growth?
What we do
Understand how your channels actually function, not just how they are designed
Identify gaps between sell-in and real sell-out performance
Surface inefficiencies, leakages, and channel conflicts
Assess how your products show up across retail environments
Compare channel performance with how competitors are winning
What you gain
A clear view of where execution is working and where it is not
Insight into the real drivers of channel performance
A more focused and effective channel strategy
Better control over distribution quality and retail outcomes
Right for you if
Growth is uneven across channels without a clear reason
You have distribution but not consistent performance
Retail execution feels difficult to control
Some channels outperform others without clear explanation
05
Patient Intelligence

Patient Journey Intelligence

Map the full patient pathway , from symptom recognition to treatment adherence , and find where your brand can intervene.

?
Patients do not move in straight lines. Their journeys are often delayed, interrupted, or shaped by factors that are easy to overlook. The question we answer: What does the patient journey actually look like, and where are the moments that determine outcomes?
What we do
Map real patient journeys across stages and interactions
Identify barriers that delay or disrupt progress
Understand emotional and practical decision drivers
Analyse where and why drop-offs happen
Translate insights into opportunities for intervention
What you gain
A realistic view of how patients navigate the system
Clarity on where journeys break down
Better opportunities to improve engagement and adherence
More patient-centric strategies grounded in real behaviour
Right for you if
Patients are dropping off or not completing treatment
Journeys feel complex and difficult to understand
You want to design more patient-centric solutions
Outcomes are not aligned with expectations
06
Influence Intelligence

Consumer & Retail Influence Intelligence

Identify who shapes purchase decisions in your category , from shelf influencers to digital communities , and build strategies to win their advocacy.

?
What happens at the point of sale often matters more than what happens in marketing. This is where decisions are made, changed, or lost. The question we answer: What actually drives choice in the retail moment, and how can you influence it more effectively?
What we do
Understand how consumers behave in real purchase environments
Identify what drives attention, consideration, and conversion
Assess the role of retailers, promoters, and in-store execution
Evaluate how your brand shows up versus competitors
Pinpoint where influence is being won or lost
What you gain
A clearer understanding of what drives conversion at retail
Stronger alignment between brand intent and retail reality
More effective in-store and channel strategies
Greater control over the moments that influence decisions
Right for you if
Awareness is strong but conversion is inconsistent
Retail execution varies significantly across locations
You want to improve in-store impact and visibility
Competitors are winning closer to the point of purchase
Industries
Start a Brief →
Related Reading
Article · Trade Intelligence

Why trade margin erosion is a strategy problem, not a pricing problem

Most brands treat margin compression as a finance issue. The brands that fix it permanently treat it as a channel architecture decision.

Read Article →
Guide · Regulatory Access

How regulatory intelligence creates first-mover advantage in emerging markets

The brands that enter a market six months ahead of competitors don't have better products , they have better regulatory intelligence.

Read Guide →
Research · KOL Strategy

The five mistakes companies make when mapping medical influence

KOL mapping done wrong wastes medical affairs budgets and damages credibility. Here's what rigorous influence intelligence looks like.

Read Research →
Pharmaceutical Company · GCC & South Asia · 2024
Trade & Execution Pharma · KOL & Channel Intelligence

Rebuilding channel and KOL execution intelligence for a specialty pharma brand across six GCC and South Asian markets

A specialty pharmaceutical company had strong clinical data but weak commercial execution. Prescriber engagement was fragmented, channel margins were eroding across three key markets, and the regulatory pathway in two new geographies remained unmapped , stalling a strategic expansion plan worth over USD 180 million.

The Core Challenge

The brand had no structured KOL engagement framework in two priority markets. Trade margins were 11 percentage points below category benchmark. Regulatory submissions had stalled due to incomplete landscape mapping. The commercial team needed intelligence across three dimensions simultaneously , with a board presentation in 14 weeks.

Cap7tara deployed a specialist execution intelligence team across all six markets , conducting 340+ physician interviews, mapping 180 KOLs by influence tier, rebuilding the trade margin architecture, and delivering a full regulatory access brief for both new geographies. All three workstreams were completed inside the 14-week window.

Read the Full Case Study →
180+
KOLs mapped across 6 marketsBy influence tier and therapeutic area
11pp
Margin gap vs. category benchmark recoveredThrough trade structure redesign
USD 180M+
Expansion opportunity unlockedAcross two new geographies
14 wk
All three workstreams deliveredConcurrent execution across 6 markets

"We came to Cap7tara with three separate problems and left with one integrated intelligence platform. The KOL mapping alone changed how our medical affairs team operates permanently."

VP Commercial · Specialty Pharma Group
✉
Write to us directly at hello@cap7tara.com

Ready to turn strategy into
on-ground execution?

Start a Conversation →